These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 9435229)

  • 1. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).
    Achen MG; Jeltsch M; Kukk E; Mäkinen T; Vitali A; Wilks AF; Alitalo K; Stacker SA
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):548-53. PubMed ID: 9435229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
    Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
    EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3.
    Achen MG; Roufail S; Domagala T; Catimel B; Nice EC; Geleick DM; Murphy R; Scott AM; Caesar C; Makinen T; Alitalo K; Stacker SA
    Eur J Biochem; 2000 May; 267(9):2505-15. PubMed ID: 10785369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development.
    Kukk E; Lymboussaki A; Taira S; Kaipainen A; Jeltsch M; Joukov V; Alitalo K
    Development; 1996 Dec; 122(12):3829-37. PubMed ID: 9012504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1.
    Wise LM; Veikkola T; Mercer AA; Savory LJ; Fleming SB; Caesar C; Vitali A; Makinen T; Alitalo K; Stacker SA
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3071-6. PubMed ID: 10077638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers.
    Stacker SA; Stenvers K; Caesar C; Vitali A; Domagala T; Nice E; Roufail S; Simpson RJ; Moritz R; Karpanen T; Alitalo K; Achen MG
    J Biol Chem; 1999 Nov; 274(45):32127-36. PubMed ID: 10542248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.
    Lee J; Gray A; Yuan J; Luoh SM; Avraham H; Wood WI
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1988-92. PubMed ID: 8700872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
    Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
    J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2.
    Kirkin V; Mazitschek R; Krishnan J; Steffen A; Waltenberger J; Pepper MS; Giannis A; Sleeman JP
    Eur J Biochem; 2001 Nov; 268(21):5530-40. PubMed ID: 11683876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
    Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
    EMBO J; 1996 Apr; 15(7):1751. PubMed ID: 8612600
    [No Abstract]   [Full Text] [Related]  

  • 11. The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man.
    Baldwin ME; Catimel B; Nice EC; Roufail S; Hall NE; Stenvers KL; Karkkainen MJ; Alitalo K; Stacker SA; Achen MG
    J Biol Chem; 2001 Jun; 276(22):19166-71. PubMed ID: 11279005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic processing regulates receptor specificity and activity of VEGF-C.
    Joukov V; Sorsa T; Kumar V; Jeltsch M; Claesson-Welsh L; Cao Y; Saksela O; Kalkkinen N; Alitalo K
    EMBO J; 1997 Jul; 16(13):3898-911. PubMed ID: 9233800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability.
    Stacker SA; Vitali A; Caesar C; Domagala T; Groenen LC; Nice E; Achen MG; Wilks AF
    J Biol Chem; 1999 Dec; 274(49):34884-92. PubMed ID: 10574962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia.
    Lymboussaki A; Olofsson B; Eriksson U; Alitalo K
    Circ Res; 1999 Nov; 85(11):992-9. PubMed ID: 10571529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant.
    Whittle C; Gillespie K; Harrison R; Mathieson PW; Harper SJ
    Clin Sci (Lond); 1999 Sep; 97(3):303-12. PubMed ID: 10464055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast.
    Dunk C; Ahmed A
    Histol Histopathol; 2001 Apr; 16(2):359-75. PubMed ID: 11332691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.
    Mäkinen T; Veikkola T; Mustjoki S; Karpanen T; Catimel B; Nice EC; Wise L; Mercer A; Kowalski H; Kerjaschki D; Stacker SA; Achen MG; Alitalo K
    EMBO J; 2001 Sep; 20(17):4762-73. PubMed ID: 11532940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors.
    Pajusola K; Aprelikova O; Pelicci G; Weich H; Claesson-Welsh L; Alitalo K
    Oncogene; 1994 Dec; 9(12):3545-55. PubMed ID: 7970715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of VEGF-C and its receptors, VEGFR-2 and VEGFR-3, in endothelial cells of lymphangioma. Implication in autocrine or paracrine regulation of lymphangioma.
    Huang HY; Ho CC; Huang PH; Hsu SM
    Lab Invest; 2001 Dec; 81(12):1729-34. PubMed ID: 11742043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro.
    Marconcini L; Marchio S; Morbidelli L; Cartocci E; Albini A; Ziche M; Bussolino F; Oliviero S
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9671-6. PubMed ID: 10449752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.